Hepatitis Virus, Rheumatic Disease Connection Explored

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

References

Saadoun D, Ferfar Y, Bouyer AS, et al. Sofosbuvir plus daclatasvir for hepatitis C virus associated cryoglobulinemia vasculitis (abstract 17L). Arthritis Rheumatol. 2016;68(suppl 10). 17L.
Singh JA, Saag KG, Bridges SL Jr., et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheum. 2016 Jan;68(1):1–26.
Pietrograndea M, De Vitab S, Zignego AL, et al. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev. 2011 Jun;10(8):444–454.
Mahale P, Kontoyiannis DP, Chemaly RF, et al. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol. 2012 Dec:57(6):1177–1185.

The FDA modifies rituximab prescribing information to stress risk of hepatitis B virus reactivation

Keep a hepatitis C virus infection from hindering RA treatment

Hepatitis B virus (HBV) associated polyarteritis nodosa (PAN) is an increasingly rare vasculitis in developed countries due to advances in HBV vaccination and antiviral therapy. However, the condition does persist, and rheumatologists should consider it when evaluating vasculitis cases. Below, we discuss a case that illustrates the varied clinical presentations PAN can encompass. A high…

Research finds patients with chronic HCV infection more likely to develop RA, especially men

References

Hepatitis Reaction with Rituximab Sparks Drug Safety Alert

Meet the HEP C Challenge

Case Report: Diagnosing, Treating Hepatitis B-Linked Polyarteritis Nodosa

Hepatitis C Virus Infection Associated with Rheumatoid Arthritis

References

Related Articles